Investors tell Trinity Biotech to find a buyer

Company shares collapsed 50% after it withdrew key heart attack test

Trinity Biotech, the Bray-based maker of medical diagnosis equipment, has been told by investors to find a buyer for the company.

Trinity Biotech’s shares collapsed 50 per cent last week after it agreed to withdraw a key heart attack test from trial following concerns by regulators. Several investors in the company, whose shares trade on New York’s Nasdaq stock market, were also critical of its management team. The company said it would take ...